The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Journal: Nature Immunology

Published: 2020-08-31

DOI: 10.1038/s41590-020-0769-3

Affiliations: 10

Authors: 31

Go to article
Institutions Share
National Cancer Center (NCC), Japan 0.40
National Cancer Center Hospital East, Japan 0.32
Nagoya University, Japan 0.15
Hitachi, Ltd., Japan 0.06
National Cancer Center Hospital, Japan 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER